JACOBIO PHARMACEUTICALS GROUP CO., LTD. Funds and ETFs Jacobio Pharmaceuticals Group Co., Ltd.
Equities
1167
KYG4987A1094
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.75 HKD | -1.69% |
|
+4.17% | -51.66% |
ETFs positioned on Jacobio Pharmaceuticals Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.85% | 4 M€ | -27.92% |
Jacobio Pharmaceuticals Group Co Ltd is a China-based investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-3068 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly conducts business within the domestic market.
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.652
CNY
Average target price
3.954
CNY
Spread / Average Target
+139.41%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -51.66% | 180M | |
| +18.07% | 125B | |
| +14.32% | 109B | |
| -3.14% | 24.74B | |
| +2.71% | 22.67B | |
| -9.95% | 18.14B | |
| -41.04% | 16.67B | |
| -12.59% | 16.64B | |
| +1.29% | 13.45B | |
| +23.47% | 11.32B |
- Stock Market
- Equities
- 1167 Stock
- Funds and ETFs Jacobio Pharmaceuticals Group Co., Ltd.
